AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016
Feb 12, 2016
30583_dirs_2016-02-12_e8aed7e7-26e8-4297-8856-84e828eeeedb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-12-31
Reporting Person: BAFFI ROBERT (EVP, Technical Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-09 | Common Stock | G | 2500 | — | Disposed | 97000 | Direct |
| 2015-06-09 | Common Stock | G | 2500 | — | Acquired | 31676 | Indirect |
| 2015-10-31 | Common Stock | A | 26 | $51.2635 | Acquired | 97026 | Direct |
Footnotes
F1: On June 9, 2015 the reporting person gifted 2,500 shares of common stock to his family trust. The reporting person is the trustee.
F2: Represents shares acquired by the reporting person on October 31, 2015 pursuant to the issuer's Employee Stock Purchase Plan.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19